Return to Article Details COMBINATION THERAPY WITH NOVEL HORMONE AGENT AND PARP INHIBITORS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: INITIAL EXPERIENCE AT THE UROLOGY DEPARTMENT, CHO RAY HOSPITAL Download Download PDF